← SynDRA
DONEPEZIL
SynDRA canonical compound SYN0000507 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | ACHE |
| Mechanism of action | Acetylcholinesterase inhibitor |
| Indication | Alzheimer's disease |
| Disease area | neurology/psychiatry |
All known targets
- ACHE
- ABCB1
- Ache
- BACE1
- BCHE
- Bche
- CHRNE
- Chat
- HRH3
- KCNH2
- MAOB
- Maob
Mechanisms of action (all sources)
- Acetylcholinesterase inhibitor
- ACHE INHIBITOR
- ACHE MODULATOR
Drug classes
- Cholinesterase Inhibitors
- Central Nervous System Agents
- Cholinergic Agents
- Enzyme Inhibitors
- Neurotransmitter Agents
- Nootropic Agents
- Cholinesterase Inhibitor
ATC classes
- N06D · ANTI-DEMENTIA DRUGS
Cross-references
Synonyms
- aricept
- donepezil hydrochloride
- donepezil HCl
- donezpil hydrochloride
- donezpil
- donezpil HCl
- donepezilium oxalate trihydrate
- donepezilium oxalate
- donepezil oxalate
- E2020
- E-2020
- Donepezilo
- D-797
- Donaz
- Donepezil (transdermal patch, Alzheimer's disease)
- 8SSC91326P
- 1-benzyl-4-((5,6-dimethoxy-1-indanon-2-yl)methyl)piperidine
- D797
- donepezilo
- donepezilum
- Domepezil
- CHEBI:53289
- donepezil hydrochlorid
- RefChem:5777
- DTXCID0028292
- N06DA02
- Aricept
- C24H29NO3
- MFCD00912833
- 1-Benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine
- Donepezil [INN:BAN]
- HSDB 7743
- NSC 737535
- NSC 758882
- NCGC00167537-01
- (S)-E2020 (free base)
- UNII-8SSC91326P
- Allydone (TN)
Reported adverse events
- Headache
- Syncope
- Vomiting
- Hallucination
- Abdominal pain
- Weight
- Fatigue
- Dizziness
- Insomnia
- Nausea
- Seizure
- Arthritis
Look up DONEPEZIL in the interactive SynDRA portal →